News

Investor's Business Daily on MSN1h
Sarepta Stock Soars After FDA Says It Can Resume Drug Shipments
Sarepta stock soared after the FDA said the biotech company can resume shipments of a controversial gene therapy drug.
Stock market today: Dow, S&P 500, Nasdaq slip as earnings roll in, Fed decision looms
US stocks gave up earlier gains on Tuesday as investors digested a wave of corporate earnings and economic data, while ...
Stock market today: S&P 500, Nasdaq rise as earnings flood in and focus turns to the Fed
US stocks pared earlier small gains on Tuesday, but kept a bid for more records in play as investors combed through a rush of ...
BioPharma Dive10h
Adaptimmune, seeking to stay afloat, sells off cell therapies
A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.
The most important woman in bonds says investors now have unrealistic expectations
Desai believes it's a "good time for fixed income," but wants to see more realistic investor expectations. Generations out there in the past got accustomed to getting just 1% -2.5% for investing in 10 ...
North American Morning Briefing: Stock Futures Rise as Investors Weigh Trade Talks, Earnings
-U.S. futures for the S&P 500 and Dow Jones Industrial Average rose 0.1% and Nasdaq futures gained 0.3%. Earnings will come today from Boeing, Spotify, United Health, Procter & Gamble, Visa and PayPal ...
Sarepta will resume gene therapy shipments after FDA review of recent patient death
Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy ...